Article révisé par les pairs
Titre:
  • Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
Auteur:Rothenberg, Marc E; Klion, Amy D; Roufosse, Florence; Kahn, J.E.; Weller, Peter F; Simon, Hans Uwe
Informations sur la publication:The New England journal of medicine, 358, 12, page (1215-1228)
Statut de publication:Publié, 2008-03
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Antibodies, Monoclonal -- adverse effects
Antibodies, Monoclonal -- therapeutic use
Double-Blind Method
Drug Therapy, Combination
Eosinophils -- drug effects
Female
Glucocorticoids -- administration & dosage
Humans
Hypereosinophilic Syndrome -- drug therapy
Hypereosinophilic Syndrome -- genetics
Interleukin-5 -- immunology
Leukocyte Count
Male
Middle Aged
Oncogene Proteins, Fusion -- genetics
Prednisone -- administration & dosage
Receptor, Platelet-Derived Growth Factor alpha -- genetics
Treatment Failure
mRNA Cleavage and Polyadenylation Factors -- genetics
Note générale:Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0028-4793
info:doi/10.1056/NEJMoa070812
info:pii/NEJMoa070812
info:scp/40949146020
info:pmid/18344568